home > news > detailed info

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

DFE Pharma

Goch, Germany (June 7th 2022)
– DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team.

DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally. A senior HR professional with decades of experience with global corporates, Mans joins coming from Royal Reesink (the Netherlands), a global distributor and services provider employing over 3,000 people worldwide, where she worked as Group HR Director.

Speaking on her new role, Mans explains: “DFE Pharma is recognized for having some of the best people in the industry working across its portfolio and I’m really looking forward to building on this reputation and continuing to do the best for our employees. As a rapidly growing global excipient business, expanding across many new and exciting areas in the pharma and biopharma sectors, we have many reasons why people would like to be a part of our journey. A big part of our continuing success will be how we develop and support our teams, be that leaders, researchers or business management staff,” says Mans.

Announcing the senior appointment, DFE Pharma CEO Martti Hedman said, "We are delighted to welcome Marie-Louise Mans to the Leadership Team. Her wealth of experience in leadership development, organizational planning, and HR strategy, in general, is critical to us in the current competitive recruitment climate. Marie-Louise has overseen the HR function of multiple global companies and we are excited to have someone of her caliber to lead this area.”

For more information on DFE Pharma, visit:
phone +49 2823 9288 770
email Klever Strasse 187 P.O. Box 20 21 20 47568 Goch
Print this page
Send to a friend
News and Press Releases

COPA-DATA USA Announces Office Move to Accommodate Accelerated Growth

COPA-DATA's New Facility in New Jersey Reinforces Innovative Culture and Commitment to Providing Industry-Leading Technology COPA-DATA USA, “We are excited to relocate to our new, larger office in New Jersey,” commented Ray Giffen, Managing Director COPA-DATA USA. “This move represents another significant milestone for our company. The new office space better accommodates our growing team and enables us to hire additional talent that will allow us to continue providing industry-leading support and service.”
More info >>

White Papers

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Pharm-Olam, LLC

Over the past decade, biopharmaceutical companies have increasingly turned to emerging markets as a way to reduce clinical trial costs and timelines. Areas such as Eastern Europe, India, and Latin America—with their ready population of treatment naïve patients—can be an answer to the intense competition for patients seen in developed markets. Many of the countries within these regions may now be considered as “emerged” countries but yet, conducting trials in these regions does require some special attention and expertise. Before deciding to conduct studies in these areas, companies should have a full appreciation for the ethical, medical, regulatory, legal, and operational hurdles that must be surmounted for success. Here we highlight a number of those issues and offer our recommendations for how sponsor companies can deal with them effectively.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement